RE:Endo is our partner.........I have seen very little about ENDO mentioned. I do remember the last phase III ending right in the middle of tax loss season ( that's a same ) I believe ENDO will be at our side on the 27th of Feb. <br /> <br /> <h3 style="box-sizing: border-box; outline: 0px; font-family: Arial, sans-serif; line-height: 22px; color: rgb(68, 105, 125); margin: 0px; font-size: 16px; padding: 0px;"> Endo is our partner.........</h3> <div class="post-content" style="box-sizing: border-box; outline: 0px; color: rgb(0, 0, 0); font-family: Arial, sans-serif; font-size: 14px; line-height: 18.1818px;"> Endo is BIG and smart. Endo controls Valstar....why doesn't Endo trade in chemo based Valstar with little efficacy for the non-toxic, more efficacious MCNA?<br style="box-sizing: border-box; outline: 0px;" /> <br style="box-sizing: border-box; outline: 0px;" /> An interesting discussion...."Indeed"<br style="box-sizing: border-box; outline: 0px;" /> <br style="box-sizing: border-box; outline: 0px;" /> GLTA<br style="box-sizing: border-box; outline: 0px;" /> Sqr</div> <br style="box-sizing: border-box; outline: 0px;" /> <font color="#000000" face="Arial, sans-serif"><span style="font-size: 14px; line-height: 18.1818px;">PS - Mitomycin was said to be an option in our phase III that people "weren't interested in" and therefore drove low enrolment....at the FDA meeting they said there was a SHORTAGE of Mitomycin..."pick a lane"...also NO mention of the BCG shortage at FDA show.</span></font>